Objective To estimate the prevalence and risk of ischemic stroke associated with metabolic syndrome.
Introduction
The distribution of body fat has been reported to be closely related to metabolic disorders. Visceral obesity or visceral fat accumulation without obesity is closely associated with what Matsuzawa et al (1) describe as "visceral fat syndrome". Reaven (2) describes this condition as "Syndrome X" consisting of metabolic and circulatory disorders such as, insulin resistance, glucose intolerance, hypertriglyceridemia, hypertension (HT), decreased plasma concentration of high-density lipoprotein cholesterol (HDL-C) and increased plasma concentration of low-density lipoprotein cholesterol (LDL-C). Subsequently, several other metabolic abnormalities have been associated with this syndrome, including obesity, and abnormalities in fibrinolysis and coagulation (3, 4) . The syndrome has also been given several other names, including metabolic syndrome, insulin resistance syndrome, and the deadly quartet (5, 6) . A unifying definition would allow physicians to assess whether the clustering of risk factors is associated with an increased risk of ischemic stroke in addition to the risk associated with the individual components.
Recently, we demonstrated that preperitoneal and subcutaneous fat thickness on ultrasonography could reflect body fat distribution more accurately, and these measurements were useful in evaluating disorders of metabolism, HT and atherosclerosis in both women and men (7, 8) . Thus, the current study was undertaken to investigate the accumulation of visceral fat by ultrasonography and the prevalence of ischemic stroke morbidity associated with metabolic syndrome.
2004. Patients with cerebral hemorrhage and severe cardiorenal or nutritional disorders that would affect blood pressure, lipid and glucose metabolism were excluded. One hundred ninety-seven patients with ischemic stroke were enrolled in the study. Three hundred fifty-six control subjects without a clinical history of cerebrovascular disease (CVD) or present neurological abnormalities were recruited at the same time from Seiyo Municipal Nomura Hospital. Informed consent for the procedure was obtained from each patient. All procedures were approved by the Ethics Committee of Seiyo Municipal Nomura Hospital.
Case definitions
Clinical syndrome of ischemic stroke was defined as rapidly developing clinical symptoms and/or signs of focal and at times global loss of brain function, either with symptoms or leading to earlier death, and with no apparent cause other than that of vascular origin. CT image of acute ischemic stroke was defined as acute onset of stroke with normal CT brain findings followed by sequential changes in CT lesions. Recent infarct in a clinically relevant area of the brain on CT scan has also been included. Patients were divided into four groups according to clinical diagnosis and CT findings: those with atherothrombotic infarction, lacunar infarction, and cardioembolic infarction and those with unclassifiable infarction (9) .
Evaluation of risk factors
Information on demographic characteristics and risk factors was collected using the clinical files in all cases. We measured blood pressure in the right upper arm of patients in a sedentary posture using a standard sphygmomanometer. We defined a smoker as a subject with a pack-years index >0 (pack-years was defined as packs of cigarettes per day multiplied by years smoked). Total cholesterol (T-C), triglyceride (TG) and HDL-C were measured within 24 hours after admission under a fasting condition. History of anti-hypertensive and anti-lipidemic drug use was also evaluated.
Ultrasound image analysis
Regarding the measurement of fat thickness by ultrasonographic evaluation (Hitachi EUB-565 or Aloka SSD-2000) using a 7.5 MHz linear type B-mode probe, the subjects were placed in the supine position, the probe was held perpendicular to the skin at the epigastrium, and vertical scanning was performed along the abdominal median from the processus xiphoideus to the umbilicus to measure the maximal thickness of preperitoneal fat (Pmax) at the anterior surface of the liver and minimal thickness of the subcutaneous fat (Smin) of the abdomen (10).
Metabolic syndrome
We applied the condition-specific cut-off points for metabolic syndrome from the recent National Cholesterol Education Program Adult Treatment Panel III (NCEP-ATP III) (11) and the World Health Organization (WHO) (12) report, with modifications. Metabolic syndrome was defined as at least 3 of the following 5 conditions: visceral obesity assessed by ultrasonography, HT, hypertriglyceridemia, low HDL-C and diabetes mellitus (DM).
Visceral obesity shown by body mass index (BMI) > = 25.0 kg/m 2 (13) and Pmax > = 0.8 mm (equal to visceral fat accumulation > = 100 cm 2 as measured by computed tomography) (14) . Hypertension was defined as systolic blood pressure (SBP) > = 140 mmHg or diastolic blood pressure (DBP) > = 90 mmHg or those who had been treated for hypertension. Hypertriglyceridemia was identified based on TG concentrations > = 150 mg/dl. Low HDL-C level was identified by an HDL-C <40 mg/dl in men or <50 mg/dl in women, or those who had been treated for dyslipidemia. Diabetes mellitus was defined as any history of treatment for diabetes mellitus.
Statistical analysis
All values are expressed as mean ± standard deviation (SD), unless otherwise specified. Statistical analysis was performed using SPSS 10.0J (Statistical Package for Social Science, Inc., Chicago, IL, USA). The prevalence among control subjects and ischemic stroke patients was compared by chi-square test. The differences among groups were analyzed by the Mann-Whitney U-test. The relationships between ischemic stroke and risk factors were examined by logistic multiple regression analysis. Table 1 shows the clinical characteristics of 356 control subjects and 197 ischemic stroke patients. Body mass index, SBP, DBP, prevalence of anti-hypertensive drug use, T-C, TG, HDL-C, Pmax, and Smin were significantly higher in patients with ischemic stroke than in the control subjects. There were no inter-group differences in sex, or age distribution, smoking status, prevalence of anti-lipidemic drug use or history of DM.
Results

Background of subjects
Distribution of metabolic syndrome component conditions in control subjects and ischemic stroke patients
Distribution of the component conditions and the full metabolic syndrome in both control subjects and patient groups is shown in Table 2 . The full metabolic syndrome frequency of component conditions > = 3 was significantly higher in the ischemic stroke patients compared with that in control subjects. The association of metabolic syndrome with ischemic stroke was further studied in terms of the subtypes of stroke as well as CT findings of the lesions. We found 80 cases of atherothrombotic infarction, 97 of lacunar infarction, 16 control subjects and atherothrombotic infarction patients in the distribution, suggesting an effect of metabolic syndrome on the risk for atherothrombotic infarction.
Presence and odds ratio of risk factors in control subjects and in atherothrombotic infarction patients
Using 2 test, we also analyzed the risk of atherothrombotic infarction in relation to the presence of metabolic syndrome and different component conditions of the syndrome (Table 3 ). In the syndrome model, the unadjusted odds ratio (OR) 95% confidence interval (CI) for metabolic syndrome and sex were 3.00 (1.66-5.41) and 1.65 (1.01-2.71), respectively. In the component model, the unadjusted OR (95% CI) for visceral obesity, HT, hypertriglyceridemia and DM were 2.51 (1.43-4.39), 3.12 (1.71-5.68), 2.57 (1.25-5.28) and 2.64 (1.39-5.03), respectively. Moreover, for each disease definition, 2 models after adjustment for sex, age and smoking status by logistic regression are presented: 1 for the full metabolic syndrome and another for the 5 component conditions. Metabolic syndrome was significantly associated with atherothrombotic infarction (OR, 3.08; 95% CI, 1.69-5.61), and had the largest OR of any of the component conditions in each of the 2 models. In the component model, visceral obesity, HT and DM demonstrated a significant association. Although lacunar infarction was not significantly associated with metabolic syndrome in the syndrome model, it was significantly associated only with HT in the component model (OR, 4.07; 95% CI, 2.20-7.54).
Odds ratio of atherothrombotic infarction associated with metabolic syndrome
Multiple logistic regression analysis for atherothrombotic infarction was performed using sex, age, smoking and metabolic syndrome as variables in these subjects (Fig. 1 ). An in- Values are number (%). CC: component conditions of the metabolic syndrome defined as the 5 following conditions, visceral obesity, hypertension, low HDL cholesterolemia, hypertriglyceridemia, and diabetes mellitus. * creased risk for atherothrombotic infarction was associated with increases in risk factors for metabolic syndrome. Compared to those in the no component condition, after adjustment for covariates, the odds ratio was 2.68 (95% CI, 1.46-4.92) for those in the 1-2 component conditions, and 8.61 (95% CI, 2.73-27.2) for those in the full metabolic syndrome.
Discussion
In the current study, we applied the modified criteria for metabolic syndrome recently proposed by NCEP-ATP III (11) and WHO (12) to both the control subjects and the ischemic stroke patients. Metabolic syndrome was present in 11.2% of control subjects, 19.8% of ischemic stroke patients, 27.5% of atherothrombotic infarction patients and 15.5% of lacunar infarction patients. Importantly, the metabolic syndrome was associated with an increased risk for atherothrombotic infarction with an odds ratio of 3.08. Compared to those with no component conditions of metabolic syndrome, after adjustment for covariates, the odds ratio (95% CI) was 8.61 (2.73-27.2) for those in the metabolic syndrome.
In previous studies, the prevalence of metabolic syndrome varied widely, primarily due to different definitions of the syndrome or selection of a different subgroup. In a population-based, prospective cohort study of 1,209 Finnish men aged 42 to 60 years at baseline who were initially without CVD, cancer, or DM, the prevalence of metabolic syndrome ranged from 8.8% to 14.3%, depending on definitions based on the NCEP and WHO with modification (15) . In the 10,357 subjects examined in the Third National Health and Nutritional Examination Survey (NHANES III), Ninomiya et al (16) reported that metabolic syndrome using the NCEP-ATP III definition was 24.0%. In the Japanese study, visceral obesity (visceral circumference > = 85 cm in males), hypertension (SBP/DB> = 130/85 mmHg), dyslipidemia (TG > = 150 mg/dl and/or HDL-C <40 mg/dl) and elevated fasting plasma glucose (FPG > = 110 mg/dl) were observed in 25.4% of male subjects over 40 years (17) . The present study reported a lower prevalence of metabolic syndrome than these studies because there were some differences in the definition in visceral obesity, blood pressure and glucose metabolism.
In this study, we found that the presence of metabolic syndrome was associated with an increased risk of ischemic stroke, especially atherothrombotic infarction. Lakka et al (15) and McNeill et al (18) demonstrated that even in the absence of DM or prior CVD, the presence of metabolic syndrome was associated with a significant increase in the risk of CVD over an 11-year follow-up period. Another population-based study (19) reported that the risk of incident CVD was found to increase with the degree of component conditions of metabolic syndrome and increased by >5-fold in those with 4 or more component conditions compared to those with only 1 component. In the present study, ischemic stroke patients were divided into four groups according to clinical diagnosis and CT findings. As the number of component conditions of metabolic syndrome increased, the risk of atherothrombotic infarction increased. These data indicate that the risk of atherosclerotic CVD is increased in an incremental fashion with various component conditions of metabolic syndrome and give credence to the requirement of > = 3 component conditions for establishing a diagnosis of metabolic syndrome (20) . There are several etiologic subtypes in ischemic stroke; an association between atherothrombotic infarction and several components of metabolic syndrome, as observed in the present study, has been reported in another study (21) . The underlying pathophysiology of lacunar infarction is less well understood but appears to involve cerebral microatheroma formation as well as lipohyalinosis (22) . However, here, the risk of lacunar infarction was only associated with HT, and not associated with metabolic syndrome. This finding may indicate differences in the background between atherothrombotic infarction and lacunar infarction (23) . It is also conceivable that different risk factors could be involved in the etiology of ischemic stroke subtypes.
In the present study, we used both BMI > = 25.0 kg/m 2 and Pmax measured by ultrasonography as a modified definition. Visceral obesity defined by both BMI > = 25.0 kg/m 2 and Pmax > = 8.0 mm assessed visceral fat more precisely than obesity defined solely as BMI > = 25.0 kg/m 2 . Using the proposed limits for BMI > = 25.0 kg/m 2 and Pmax > = 8.0 mm, 14.6% of control subjects and 30.0% of atherothrombotic infarction patients would be considered visceral obesity, while the corresponding figures using only BMI > = 25.0 kg/m 2 would be 18.5% and 32.5%, respectively (data not shown). In the component model, visceral obesity (OR, 2.03; 95% CI, 1.09-3.77) had a greater odds of atherosclerotic infarction compared with BMI > = 25.0 kg/m 2 (OR, 1.67; 95% CI, 0.93-3.00, data not shown). Although our finding supports the hypothesis that body fat accumulation is an important predictor of atherosclerosis, the complexity of this relationship has been illustrated in recent studies in which the effect of regional adiposity on the body was more closely associated with atherosclerosis incidence than the magnitude of generalized obesity (24, 25) . Furthermore, ultrasonography could be alternatively used to estimate visceral fat, because a strong correlation between computed tomography and ultrasonography fat estimates was reported previously (10) . In addition, the reliability of ultrasonography estimations to predict ischemic stroke is reinforced by its ability to identify patients at high risk for metabolic syndrome (8, 26, 27) .
We need to be aware of limitations in interpreting the present results. Based on its cross-sectional study design, the present result is inherently limited in its ability to eliminate causal relationships between risk factors and atherothrombotic infarction. Since all participants were hospitalized patients, we could not eliminate possible effects of underlying diseases on the results. We also could not eliminate possible effects of the mediation of hypertension and dislipidemia on the present findings. Antihypertensive drug use varied from 36.5% in control subjects to 59.4% in ischemic stroke patients. The latter is unlikely because only 2.2% of the control subjects and 3.6% of the ischemic stroke patients received lipid-lowering treatment. Secondary prevention interventions for obesity, HT, dyslipidemia and DM may be successful in reducing risk factors, thus attenuating the observed association of risk factors with disease. These points need to be addressed again in a large population-based sample in a prospective fashion.
In summary, the clustering of cardiovascular risk factors called metabolic syndrome, based on NCEP-ATP III and WHO criteria with modifications, was seen in 27.5% of atherothrombotic infarction patients and in 11.2% of control subjects. Metabolic syndrome increases the risk of cardiovascular morbidity, and its identification may thus be important in risk assessment and in the treatment of patients.
